HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liqiang Duan Selected Research

ras Proteins

1/2023Epitranscriptic regulation of HRAS by N6-methyladenosine drives tumor progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liqiang Duan Research Topics

Disease

5Neoplasms (Cancer)
01/2023 - 10/2018
3Neoplasm Metastasis (Metastasis)
01/2023 - 01/2021
1Hypoxia (Hypoxemia)
11/2023
1Colorectal Neoplasms (Colorectal Cancer)
11/2023
1Lung Neoplasms (Lung Cancer)
01/2022
1Adenocarcinoma of Lung
01/2022
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021

Drug/Important Bio-Agent (IBA)

2Phosphotransferases (Kinase)IBA
11/2023 - 01/2023
26-methyladenineIBA
01/2023 - 01/2021
2N-methyladenosineIBA
01/2023 - 01/2021
2Long Noncoding RNAIBA
01/2022 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2021 - 10/2018
1Proteins (Proteins, Gene)FDA Link
11/2023
1ras ProteinsIBA
01/2023
1Histones (Histone)IBA
01/2022
1Heterogeneous-Nuclear Ribonucleoprotein KIBA
01/2022
1Small Interfering RNA (siRNA)IBA
01/2022
1LigandsIBA
01/2020
1Immune Checkpoint ProteinsIBA
01/2020
1AntibodiesIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Blocking AntibodiesIBA
01/2020
1Programmed Cell Death 1 ReceptorIBA
01/2020
1MicroRNAs (MicroRNA)IBA
10/2018

Therapy/Procedure

1Therapeutics
01/2020